https://www.selleckchem.com/pr....oducts/rocilinostat-
Adherence and satisfaction are favoured by training programmes in the use of the parenteral route. The results in rheumatic diseases other than rheumatoid arthritis (RA) are very scarce and do not enable obtaining conclusive data. Parenteral MTX can be an alternative to the use of oral MTX, due to its profile of efficacy, safety, adherence and pharmacoeconomic results, especially in those patients with RA. Parenteral MTX can be an alternative to the use of oral MTX, due to its profile of efficacy, safety, adherence and pha
Curtir
Comentario
Compartilhar
